Institute for Community Medicine, University Medicine Greifswald, Germany; German Centre for Cardiovascular Research (DZHK), Partner site Greifswald, Greifswald, Germany.
Department of Internal Medicine B - Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University Medicine Greifswald, Germany; German Centre for Cardiovascular Research (DZHK), Partner site Greifswald, Greifswald, Germany.
Nutr Metab Cardiovasc Dis. 2022 Jul;32(7):1693-1702. doi: 10.1016/j.numecd.2022.03.022. Epub 2022 Apr 2.
The definition of the metabolic syndrome consists of five components. The underlying measurements are subject to intra-individual variability. This repeated measurements study investigated the impact of intra-individual measurement variability on the stability of the diagnosis of metabolic syndrome over 12 months.
Twenty-five employees of the University Medicine Greifswald aged 22-70 years were examined once a month over one year. Examinations included blood sampling and anthropometric and blood pressure measurements. Laboratory measurements included glucose, cholesterol (high-density lipoprotein [HDL], and low-density lipoprotein [LDL]), and triglycerides. The metabolic syndrome was defined according to the International Diabetes Federation modified for non-fasting blood samples. Variations in continuous metabolic markers were assessed using coefficients of variation (CV) and intra-class correlation coefficients (ICC). Overall eight participants (32%) were categorized at least once within 12 months as having a metabolic syndrome; in none of those metabolic syndrome was found consistently over the study follow-ups. The Cohen's Kappa for metabolic syndrome was 0.57. CV was highest for triglycerides (27.5%) followed by glucose (10.1%), LDL- (9.5%), and HDL-cholesterol (8.6%). ICC's were lowest for glucose (0.51), triglycerides (0.65), systolic (0.68), and diastolic blood pressure (0.69).
We showed that the measurement of biomarkers defining the metabolic syndrome is a time-varying condition with implications for the concept of the metabolic syndrome. To account for this uncertainty in prevalence studies we propose to identify uncertain cases according to the current definition of the metabolic syndrome. For analysing associations we recommend to apply probabilistic sensitivity analyses.
代谢综合征的定义包括五个组成部分。基础测量值存在个体内变异性。本重复测量研究旨在调查个体内测量变异性对代谢综合征诊断在 12 个月内的稳定性的影响。
格赖夫斯瓦尔德大学医学中心的 25 名年龄在 22-70 岁的员工在一年中每月接受一次检查。检查包括采血以及人体测量和血压测量。实验室检查包括血糖、胆固醇(高密度脂蛋白[HDL]和低密度脂蛋白[LDL])和甘油三酯。代谢综合征根据国际糖尿病联合会(IDF)的标准进行定义,适用于非空腹血样。使用变异系数(CV)和组内相关系数(ICC)评估连续代谢标志物的变化。在 12 个月内,共有 8 名参与者(32%)至少有一次被归类为代谢综合征;在研究随访期间,没有一人始终存在代谢综合征。代谢综合征的 Cohen's Kappa 值为 0.57。甘油三酯的 CV 最高(27.5%),其次是葡萄糖(10.1%)、LDL-(9.5%)和 HDL-胆固醇(8.6%)。葡萄糖(0.51)、甘油三酯(0.65)、收缩压(0.68)和舒张压(0.69)的 ICC 最低。
我们表明,定义代谢综合征的生物标志物的测量是一种随时间变化的情况,这对代谢综合征的概念有影响。为了在患病率研究中考虑到这种不确定性,我们建议根据当前代谢综合征的定义确定不确定病例。对于分析关联,我们建议应用概率敏感性分析。